Skip to main content

Table 2 The baseline data and prognosis of patients who received reintubation within 48 h of and 48 h after extubation in the two groups

From: Effects of high-flow oxygen therapy on patients with hypoxemia after extubation and predictors of reintubation: a retrospective study based on the MIMIC-IV database

 

Treatment group n = 358

Control group n = 443

 

All reintubations n = 79

Within 48 h n = 40

48 h after n = 39

P value

All reintubations n = 81

Within 48 h n = 55

48 h after n = 26

P value

Age, median[Q1, Q3]

67.68[57.02, 78.00]

64.47[49.57, 77.97]

68.83[62.52, 77.59]

0.202

71.82[62.27, 78.93]

71.52[60.69, 78.69]

73.40[64.81, 78.74]

0.485

Male, n (%)

59(74.68)

31(77.50)

28(71.79)

0.746

48(59.26)

29(52.73)

19(73.08)

0.134

BMI, mean (SD)

29.65(5.87)

28.99(5.72)

30.38(6.02)

0.314

32.60(9.00)

31.12(8.34)

35.67(9.71)

0.051

Baseline disease

 Hypertension, n (%)

41(51.90)

18(45.00)

23(58.97)

0.309

54(66.67)

33(60.00)

21(80.77)

0.110

 Diabetes mellitus, n (%)

12(15.19)

7(17.50)

5(12.82)

0.790

13(16.05)

7(12.73)

6(23.08)

0.331

 COPD, n (%)

5(6.33)

3(7.50)

2(5.13)

1.000

9(11.11)

5(9.09)

4(15.38)

0.458

 Congestive heart failure, n (%)

23(29.11)

10(25.00)

13(33.33)

0.570

29(35.80)

17(30.91)

12(46.15)

0.277

 Myocardial infarction, n (%)

6(7.59)

4(10.00)

2(5.13)

0.675

14(17.28)

9(16.36)

5(19.23)

0.760

 Chronic kidney disease, n (%)

17(21.52)

5(12.50)

12(30.77)

0.089

21(25.93)

10(18.18)

11(42.31)

0.041

 Leukaemia, n (%)

1(1.27)

0

1(2.56)

0.494

2(2.47)

1(1.82)

1(3.85)

0.542

 Strokes, n (%)

8(10.13)

1(2.50)

7(17.95)

0.029

6(7.41)

4(7.27)

2(7.69)

1.000

 Cancer, n (%)

10(12.66)

6(15.00)

4(10.26)

0.737

16(19.75)

9(16.36)

7(26.92)

0.415

 Liver disease, n (%)

12(15.19)

7(17.50)

5(12.82)

0.790

14(17.28)

8(14.55)

6(23.08)

0.360

 SAPS-II at admission, mean (SD)

44.32(13.08)

43.30(10.86)

45.36(15.09)

0.490

47.20(13.72)

46.73(13.48)

48.19(14.45)

0.665

 Duration before extubation, median [Q1,Q3], hours

61.50[20.33, 125.27]

53.92[15.14, 110.82]

67.35[22.86, 138.07]

0.364

38.90[20.25, 131.67]

40.83[23.53, 128.29]

28.46[17.63, 127.40]

0.413

Physiological variables before extubation 4 h

 Heart rate, mean (SD)

87.28(15.55)

89.67(16.07)

84.84(14.80)

0.168

86.00(16.39)

87.03(14.03)

83.81(20.67)

0.476

 Respiratory rate, mean (SD)

19.10(4.67)

19.41(4.09)

18.78(5.23)

0.556

19.73(4.17)

19.70(4.42)

19.79(3.64)

0.920

 Tidal volume, mean (SD)

534.45(132.46)

527.92(146.70)

539.43(122.28)

0.734

454.31(111.36)

448.81(112.36)

466.35(110.87)

0.553

 MBP, mean (SD)

79.62(12.93)

81.10(13.91)

78.10(11.82)

0.304

77.45(10.11)

77.61(10.55)

77.13(9.31)

0.836

 pH, mean (SD)

7.41(0.07)

7.39(0.07)

7.42(0.06)

0.068

7.39(0.05)

7.39(0.06)

7.38(0.05)

0.831

 PaO2, median [Q1, Q3]

91.00[82.00, 107.00]

89.25[83.50, 104.62]

95.50[81.17, 110.50]

0.444

96.00[87.00, 108.00]

95.00[85.75, 106.25]

98.25[89.54, 115.00]

0.347

 PaCO2, mean (SD)

39.76(6.76)

39.52(6.60)

40.01(6.99)

0.751

44.79(10.47)

45.58(11.74)

43.10(7.01)

0.240

 SpO2, median [Q1, Q3]

97.00[95.54, 98.69]

96.50[95.00, 98.29]

97.25[96.38, 98.88]

0.088

97.25[95.50, 98.60]

97.80[95.75, 98.78]

96.50[95.56, 97.93]

0.172

 PaO2/FiO2, median [Q1,Q3]

209.00[175.50, 248.62]

208.00[170.00, 229.86]

217.50[189.75, 254.30]

0.233

220.00[187.50, 252.52]

213.00[186.50, 254.32]

221.88[192.12, 249.65]

0.712

 Mortality 28 days, n (%)

13(16.46)

4(10.00)

9(23.08)

0.206

12(14.81)

7(12.73)

5(19.23)

0.509